LymeAlert provides an easy-to-use, at-home testing kit for detecting Lyme disease in ticks removed from people or animals. This service allows users to quickly test ticks to determine potential exposure risk without needing a lab visit. The platform offers a straightforward process of tick removal, testing, and result delivery for proactive health management.
Funding
Funding not disclosed
Founders
Product
Problem
Lyme disease, a prevalent vector-borne illness, is challenging to diagnose due to delayed symptom manifestation, potentially leading to chronic complications. Early detection is critical for effective treatment and improved patient outcomes.
Solution
LymeAlert offers an at-home tick testing kit designed for the early detection of Lyme disease. The kit utilizes immunoassay technology to identify the presence of the Borrelia burgdorferi bacterium within ticks. This empowers individuals with timely, actionable information, enabling informed decisions regarding potential exposure and subsequent treatment, thereby mitigating the risk of long-term health issues. The process involves crushing the tick using an integrated device, mixing its contents with a test solution, and then inserting a test strip to obtain results within approximately 30 minutes.
Target Audience
Individuals who have been bitten by ticks and are seeking to determine potential Lyme disease exposure.
Features
- Immunoassay-based rapid screening kit for the detection of Borrelia burgdorferi in ticks.
- Integrated tick crusher for sample preparation.
- Test strip format providing qualitative results within 30 minutes.
- Patent-pending technology for early-stage detection capabilities.
- Designed for at-home use, facilitating prompt assessment of tick-borne pathogen exposure.